早期口咽癌单模式治疗后患者自报吞咽功能:人群研究
本研究基于Head and Neck 5000队列,纳入T1-2N0-2bM0口咽癌患者,比较接受手术或放疗(RT)单模式治疗者的自报吞咽功能。12个月随访时,RT组吞咽问题报告率35%,手术组23%(RR 1.3;但手术组中52%接受了辅助治疗。
要点
- 早期口咽癌选择手术或放疗均可,但放疗组12个月吞咽问题报告率数值更高(35% vs 23%),差异未达统计学显著。
- 手术组中超过半数(52%)实际接受了手术联合辅助治疗,其吞咽问题比例与单纯放疗组相似。
- 解释吞咽功能比较时需考虑治疗分配混杂及辅助治疗的实际接受情况。
核心结论
- 接受单纯手术的患者死亡率与放疗组相似,吞咽功能有改善趋势但未达统计学显著。
- 超过半数被分配至手术的患者实际接受了手术联合辅助治疗。
研究设计与样本
- 基于Head and Neck 5000研究的人群队列,纳入T1-2N0-2bM0口咽癌患者,比较手术与放疗单模式治疗者的前瞻性自报吞咽功能。
- 放疗组n=150,手术组n=150,12个月随访时采用调整基线特征的模型比较吞咽问题。
主要发现
- 放疗组基线特征较手术组不利。
- 手术组中接受辅助治疗者(n=78,52%)吞咽问题比例与单纯放疗组相似。
临床怎么用
- 早期口咽癌选择单模式治疗时,应向患者说明放疗与手术在吞咽功能上的差异未达统计学显著。
- 需告知选择手术的患者中超过半数可能实际接受辅助治疗,其吞咽结局可能与单纯放疗相似。
局限性
- 吞咽功能差异未达统计学显著,结果需谨慎解释。
- 手术组中超过半数接受了辅助治疗,削弱了单纯手术与放疗的比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single-modality treatment (surgery or radiotherapy [RT]) is a curative treatment option for early-stage oropharyngeal carcinoma (OPC) with comparable (excellent) oncological outcomes. This study aimed to compare self-reported swallowing function. METHODS: Participants with a T1-2N0-2bM0 OPC who were offered single-modality treatment and were recruited to the Head and Neck 5000 study were included. Prospectively collected self-reported swallowing function was compared between surgery and RT. RESULTS: Those offered RT (n = 150) had less favorable baseline characteristics than those offered surgery (n = 150). At 12-month follow up, RT participants reported more swallowing problems (35% vs 23%, RR 1.3; 95% CI 0.8-2.3, P = .277) in models adjusted for baseline characteristics. In those allocated to surgery who received adjuvant therapy (n = 78, 52%), the proportion with swallowing problems was similar to those allocated to RT alone. CONCLUSIONS: Participants offered surgery alone had similar mortality but improved swallowing, although this was not statistically significant. However, over half of participants offered surgery alone received surgery and adjuvant therapy.
引用
- Karsten RT, van den Brekel MWM, Smeele LE, et al. Patient-reported swallowing function after treatment for early-stage oropharyngeal carcinoma: Population-based study. Head Neck. 2020. PMID: 32141678. doi:10.1002/hed.26131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。